Old Web
English
Sign In
Acemap
>
Paper
>
Prognostic value of CYFRA 21.1 in malignant mesothelioma: A brief report of the randomized phase II trial NVALT19.
Prognostic value of CYFRA 21.1 in malignant mesothelioma: A brief report of the randomized phase II trial NVALT19.
2021
Cornedine J. de Gooijer
Vincent van der Noort
Daan van den Broek
Paul Baas
Jacobus A. Burgers
Keywords:
Oncology
value
Internal medicine
Mesothelioma
CYFRA 21-1
Medicine
Phase (waves)
Correction
Source
Cite
Save
Machine Reading By IdeaReader
4
References
0
Citations
NaN
KQI
[]